Dolby SVP sells 3,000 shares at $66.14

Dolby Laboratories, Inc. executive Shriram Revankar reported an open-market sale of company stock.

Accepted by SEC EDGAR 02/17/2026 - 06:00 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Dolby Laboratories, Inc. executive Shriram Revankar reported an open-market sale of company stock. On 02/17/2026, he sold 3,000 shares of Class A common stock at $66.14 per share. After this transaction, he beneficially owned 83,218 Class A shares, including 59,172 shares underlying restricted stock units that may be forfeited if they do not vest.

Insider Trade Summary

Net Seller: 3,000 shares

Net Sell 1 txn

Insider Revankar Shriram

Role SVP, Advanced Technology Group

Sold 3,000 shs ($198K)

Share of Position Sold 3.5%

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	3,000	$66.14	$198K

Holdings After Transaction: Class A Common Stock — 83,218 shares (Direct)

Holdings Before and After: Class A Common Stock, 86,218 to 83,218 shares (Direct)

Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. Shares held following the reported transactions include 59,172 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DLB executive Shriram Revankar report?

Shriram Revankar reported an open-market sale of Dolby Laboratories Class A shares. On 02/17/2026, he sold 3,000 shares at $66.14 per share. This transaction was reported as a direct ownership sale on a Form 4 insider trading report.

How many Dolby (DLB) shares does Shriram Revankar own after this Form 4?

After the reported sale, Shriram Revankar beneficially owned 83,218 Class A Dolby shares. This total includes 59,172 shares underlying restricted stock units, which are subject to forfeiture until they vest according to the terms of those awards.

Was the DLB insider transaction an open-market sale or another type of trade?

The filing shows the DLB insider transaction was an open-market sale. The transaction code is “S,” and it is described as a sale in an open market or private transaction, covering 3,000 Class A shares at a price of $66.14 per share.

What portion of Shriram Revankar’s DLB holdings are restricted stock units?

Out of 83,218 Class A shares beneficially owned after the trade, 59,172 shares are underlying restricted stock units. These RSUs are subject to forfeiture until they vest, meaning he does not fully own them unless the vesting conditions are satisfied.

What is Shriram Revankar’s role at Dolby Laboratories (DLB)?

Shriram Revankar is an officer of Dolby Laboratories serving as SVP, Advanced Technology Group. His role is noted in the insider report, which also confirms he is not a director and not a ten percent owner of the company’s outstanding shares.

Is Shriram Revankar’s ownership in DLB direct or through another entity?

The Form 4 indicates that Shriram Revankar’s ownership is direct. The ownership form is marked as “D” for direct, and there is no indication in the footnotes that the reported shares are held through a trust, partnership, or other indirect entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Revankar Shriram

(Last) (First) (Middle)

C/O DOLBY LABORATORIES, INC.

1275 MARKET STREET

(Street)

SAN FRANCISCO CA 94103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Advanced Technology Group

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/17/2026		S		3,000	D	$66.14	83,218(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares held following the reported transactions include 59,172 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

	/s/ Daniel Rodriguez as Attorney-in-Fact for Shriram Revankar	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.